Intriguingly, the results obtained with the ieSCI-chip also identified a small subpopulation of Bax-negative cisplatin-treated cells (Fig. 5c, right panel, marked in red box), which suggests heterogeneity among tumor cells. The gene discussed is BAX; the disease is neoplasm.